| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/21/2009 | US7563776 First sequence of human low affinity nerve growth factor receptor or a polynucleotide coding for it and a second sequence of a mutant hiv nef gene or a polynucleotide coding for it |
| 07/21/2009 | US7563775 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/21/2009 | US7563617 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 07/21/2009 | US7563596 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells |
| 07/21/2009 | US7563457 Nanoparticle assembled hollow spheres |
| 07/21/2009 | US7563448 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | CA2253348C Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 07/16/2009 | WO2009089035A1 Methods and systems for expanding ac133+ cells and directing differentiation |
| 07/16/2009 | WO2009088892A1 Liver screening method |
| 07/16/2009 | WO2009088849A2 Treatment or prevention of inflammation by targeting cyclin d1 |
| 07/16/2009 | WO2009087110A1 Secretable hiv entry inhibitory peptides for therapy of hiv infection |
| 07/16/2009 | WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | WO2009026653A8 Neuroplasticity assay |
| 07/16/2009 | WO2008121016A8 Oncological disease treating method |
| 07/16/2009 | WO2008015383A8 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 07/16/2009 | WO2007140339A8 Production of isoprenoids |
| 07/16/2009 | WO2007138253A8 Screening method |
| 07/16/2009 | WO2007138193A8 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 07/16/2009 | WO2004022771A3 Short interfering nucleic acid hybrids and methods thereof |
| 07/16/2009 | US20090181918 Inhibition of pathological angiogenesis in vivo |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181909 Vasopressin-Binding L-Nucleic Acid |
| 07/16/2009 | US20090181907 Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter |
| 07/16/2009 | US20090181456 Adipose-derived stem cells and lattices |
| 07/16/2009 | US20090181087 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090180989 Compositions and methods for delivering nucleotide sequences to vertebrates |
| 07/16/2009 | US20090180988 Id-1 and Id-2 Genes and Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 07/16/2009 | US20090180957 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 07/16/2009 | CA2711497A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | CA2711240A1 Liver screening method |
| 07/15/2009 | EP2078726A1 Secretable HIV entry inhibitory peptides for therapy of HIV infection |
| 07/15/2009 | EP2078531A2 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 07/15/2009 | EP2077863A2 Intrabodies |
| 07/15/2009 | EP2077862A2 Pathotropic targeted gene delivery system for cancer and other disorders |
| 07/15/2009 | EP1653989B1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 07/15/2009 | EP1558635B1 Vaccine |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1507561B1 Compositions for delivering nucleic acids to cells |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513565C Apoptin-associating protein |
| 07/15/2009 | CN100513560C Method for virus propagation |
| 07/14/2009 | US7560610 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560444 Formulations comprising low molecular weight heparin and a therapeutic, prophylactic or diagnostic agent; improved bioavailability; side effect reduction |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560439 Method for increasing the gene expression of transfected genes |
| 07/14/2009 | US7560437 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders |
| 07/14/2009 | US7560431 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560241 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2 |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | US7560102 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
| 07/14/2009 | CA2242542C Compositions and methods for therapeutic use |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/09/2009 | WO2009086469A2 Immunomodulatory agents and methods of use |
| 07/09/2009 | WO2009086428A2 Methods and compositions for increasing gene expression |
| 07/09/2009 | WO2009086000A2 Biomarkers for trichogenicity |
| 07/09/2009 | WO2009085277A2 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| 07/09/2009 | WO2009085275A2 Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions |
| 07/09/2009 | WO2009085274A2 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars |
| 07/09/2009 | WO2009085273A2 Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
| 07/09/2009 | WO2009085271A2 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
| 07/09/2009 | WO2009085270A2 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| 07/09/2009 | WO2009085269A2 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| 07/09/2009 | WO2009085268A2 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
| 07/09/2009 | WO2009084739A1 Method and pharmaceutical composition for treatment of cancer using bmp10 protein, |
| 07/09/2009 | WO2009084738A1 Method and pharmaceutical composition for treatment of cancer using bmp9 protein |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009082817A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | WO2009008991A3 Dna-pkcs modulates energy regulation and brain function |
| 07/09/2009 | WO2008034388A8 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 07/09/2009 | WO2008000186A8 A method for identifying novel gene and the resulting novel genes |
| 07/09/2009 | US20090178148 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 07/09/2009 | US20090178145 Methods and targets for identifying compounds for regulating angiogenesis |
| 07/09/2009 | US20090176722 Androgen-regulated PMEPA1 gene and polypeptides |
| 07/09/2009 | US20090176710 Complex for transferring an anionic substance into a cell |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176706 Materials and methods for treatment of inflammatory and cell proliferation disorders |
| 07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
| 07/09/2009 | US20090176250 Immunoliposome-Nucleic Acid Amplification (ILNAA) Assay |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175830 Oncolytic adenovirus armed with therapeutic genes |
| 07/09/2009 | US20090175825 Interferon alpha and antisense k-ras rna combination gene therapy |
| 07/09/2009 | CA2710953A1 Methods and compositions for increasing gene expression |
| 07/09/2009 | CA2710713A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | CA2710388A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710387A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710382A1 Treatment of orthopedic conditions |